Neoadjuvant chemotherapy for stage III and IV epithelial ovarian cancer: A comparative study.

被引：0
|
作者：
Loizzi, V
Cormio, G
Di Vagno, G
Resta, L
Cazzolla, A
Di Gilio, A
Cuccovillo, A
Selvaggi, L
机构：
[1] Univ Bari, Dept Ob Gyn, Bari, Italy
[2] Univ Bari, Dept Pathol, Bari, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5117
引用
收藏
页码：478S / 478S
页数：1
相关论文
共 50 条
  • [21] Neoadjuvant Chemotherapy for Advanced Epithelial Ovarian Cancer
    Hall, Tracilyn R.
    Dizon, Don S.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2016, 14 (04) : 262 - 268
  • [22] Neoadjuvant and adjuvant chemotherapy in the multidisciplinary treatment of oral cancer stage III or IV
    Grau, JJ
    Estape, J
    Blanch, JL
    Vilalta, A
    Castro, V
    Biete, A
    Daniels, M
    ORAL ONCOLOGY-EUROPEAN JOURNAL OF CANCER PART B, 1996, 32B (04): : 238 - 241
  • [23] Intraperitoneal Chemotherapy for Stage III Epithelial Ovarian Cancer - Our Experience
    Jaka, R. C.
    Zaveri, S.
    Somashekhar, S. P.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S531 - S531
  • [24] Neoadjuvant chemotherapy for stage III ovarian cancer: A single-institution experience
    Nizam, A.
    Shih, K. K.
    Shan, W.
    Bustamante, B.
    dos Santos, L.
    Frimer, M.
    Menzin, A. W.
    Sakaris, A.
    Whyte, J. S.
    Goldberg, G. L.
    GYNECOLOGIC ONCOLOGY, 2020, 159 : 132 - 133
  • [25] Dose-dense chemotherapy with paclitaxel and carboplatin in stage III-IV ovarian cancer:: Pathologic response and outcome of pilot study.
    Viret, F
    Bertucci, F
    Houvenaeghel, G
    Gravis, G
    Camerlo, J
    Capiello, M
    Genre, D
    Oziel-Taïeb, S
    Maraninchi, D
    Viens, P
    ANNALS OF ONCOLOGY, 2000, 11 : 86 - 86
  • [26] A retrospective clinical study of neoadjuvant chemotherapy for advanced epithelial ovarian cancer
    Yinghui Li
    Shaojia Wang
    Linlin Yang
    Chunmei Yin
    Hongying Yang
    OncologyandTranslationalMedicine, 2017, 3 (06) : 231 - 240
  • [27] Neoadjuvant Chemotherapy Versus Primary Debulking Surgery in FIGO Stage III and IV Epithelial Ovarian, Tubal or Peritoneal Cancer: A Systematic Review and Meta-Analysis
    Tzanis, Alexander A.
    Iavazzo, Christos
    Hadjivasilis, Alexandros
    Tsouvali, Hara
    Antoniou, George A.
    Antoniou, Stavros A.
    ONCOLOGY REVIEWS, 2022, 16
  • [28] SURVIVAL IMPACT OF SURGICAL STRATEGY IN STAGE III OR IV EPITHELIAL OVARIAN CANCER
    Delga, B.
    Lambaudie, E.
    Houvenaeghel, G.
    Andrieux, N.
    Classe, J. M.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 278 - 278
  • [29] Phase II evaluation of neoadjuvant chemotherapy and interval debulking followed by intraperitoneal chemotherapy in women with stage III and IV epithelial ovarian, fallopian tube, or primary peritoneal cancer: A Southwest Oncology Group study
    Tiersten, A.
    Liu, P.
    Smith, H.
    Wilczynski, S.
    Robinson, W.
    Markman, M.
    Alberts, D.
    GYNECOLOGIC ONCOLOGY, 2008, 108 (03) : S3 - S3
  • [30] SURVIVAL IMPACT OF SURGICAL STRATEGY IN STAGE III OR IV EPITHELIAL OVARIAN CANCER
    Delga, B.
    Lambaudie, E.
    Houvenaeghel, G.
    Andrieux, N.
    Classe, J. M.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 1473 - 1473
12345